U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Unresectable Peritoneal Biphasic Mesothelioma

MedGen UID:
1738910
•Concept ID:
C5420306
•
Neoplastic Process

Definition

Peritoneal biphasic mesothelioma that is not amenable to surgical resection. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVUnresectable Peritoneal Biphasic Mesothelioma

Recent clinical studies

Etiology

Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study.
Calabrò L, Morra A, Fonsatti E, Cutaia O, Fazio C, Annesi D, Lenoci M, Amato G, Danielli R, Altomonte M, Giannarelli D, Di Giacomo AM, Maio M
Lancet Respir Med 2015 Apr;3(4):301-9. Epub 2015 Mar 26 doi: 10.1016/S2213-2600(15)00092-2. PMID: 25819643
Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.
Magge D, Zenati MS, Austin F, Mavanur A, Sathaiah M, Ramalingam L, Jones H, Zureikat AH, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA
Ann Surg Oncol 2014 Apr;21(4):1159-65. Epub 2013 Dec 10 doi: 10.1245/s10434-013-3358-y. PMID: 24322529Free PMC Article

Therapy

Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study.
Calabrò L, Morra A, Fonsatti E, Cutaia O, Fazio C, Annesi D, Lenoci M, Amato G, Danielli R, Altomonte M, Giannarelli D, Di Giacomo AM, Maio M
Lancet Respir Med 2015 Apr;3(4):301-9. Epub 2015 Mar 26 doi: 10.1016/S2213-2600(15)00092-2. PMID: 25819643
Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.
Magge D, Zenati MS, Austin F, Mavanur A, Sathaiah M, Ramalingam L, Jones H, Zureikat AH, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA
Ann Surg Oncol 2014 Apr;21(4):1159-65. Epub 2013 Dec 10 doi: 10.1245/s10434-013-3358-y. PMID: 24322529Free PMC Article

Prognosis

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.
Magge D, Zenati MS, Austin F, Mavanur A, Sathaiah M, Ramalingam L, Jones H, Zureikat AH, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA
Ann Surg Oncol 2014 Apr;21(4):1159-65. Epub 2013 Dec 10 doi: 10.1245/s10434-013-3358-y. PMID: 24322529Free PMC Article

Clinical prediction guides

Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.
Magge D, Zenati MS, Austin F, Mavanur A, Sathaiah M, Ramalingam L, Jones H, Zureikat AH, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA
Ann Surg Oncol 2014 Apr;21(4):1159-65. Epub 2013 Dec 10 doi: 10.1245/s10434-013-3358-y. PMID: 24322529Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...